Evidence map›Paper›PMID 30455823›Full record

ArticleThe Pan African medical journal2018

Comparative

Daniel Kwame Afriyie, Linda Brakowaah Adu, Marc Dzradosi, Seth Kwabena Amponsah, Prince Ohene-Manu, Francis Manu-Ofei

Open access · goldAbstract readComparative Study
In one paragraph

Article in The Pan African medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel Kwame AfriyieGhana Police Hospital, Pharmacy Department, Accra, Ghana.
Linda Brakowaah AduDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, Central University, Accra, Ghana.
Marc DzradosiDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, Central University, Accra, Ghana.
Seth Kwabena AmponsahDepartment of Pharmacology and Toxicology, School of Pharmacy, University of Ghana, Accra, Ghana.
Prince Ohene-ManuGhana Police Hospital, Pharmacy Department, Accra, Ghana.
Francis Manu-OfeiGhana Police Hospital, Pharmacy Department, Accra, Ghana.
37 Military Hospital · GHUniversity of Ghana · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStudies on urinary tract infections (UTIs) in West Africa from 1990 to 2012 have showed moderate to high antimicrobial resistance to commonly prescribed antibiotics. Fluoroquinolones have been the main stay in the management of UTIs, but recent reports show emergence of resistance. Levofloxacin and ciprofloxacin still remain the commonest fluoroquinolones prescribed for UTIs in many settings. objective: this study sought to compare activity of ciprofloxacin and levofloxacin against clinical isolates obtained from patients with suspected UTI at the Ghana Police Hospital.

methodsMidstream urine samples from 153 suspected UTI patients who visited the Ghana Police Hospital from July 2016 to March 2017 were examined. Urine samples were cultured and isolates identified by standard biochemical and serological methods. The Kirby-Bauer disc diffusion method was used to determine susceptibility of isolates to ciprofloxacin and levofloxacin.

resultsUTI prevalence was significantly (p < 0.05) higher among female patients (74.5%) than male patients (25.5%). Clinical uropathogens isolated from urine samples were

conclusionThis study revealed emergence of resistance of uropathogens to quinolones. The isolates showed higher sensitivity to ciprofloxacin compared to levofloxacin. Rational prescribing and use of these fluoroquinolones following local susceptibility data is thus recommended.

Indexed as

AdultAnti-Bacterial AgentsBacteriaCiprofloxacinCross-Sectional StudiesDrug Resistance, BacterialFemaleFluoroquinolonesGhanaHumansIn Vitro TechniquesLevofloxacinMaleMicrobial Sensitivity TestsMiddle AgedPilot ProjectsAnti-Bacterial AgentsCiprofloxacinFluoroquinolonesLevofloxacinactivityFluoroquinolonessusceptibilityuropathogens

Identifiers

PMID30455823
PMCPMC6235466
OpenAlexW2835689810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.